Skip Ribbon Commands
Skip to main content
Menu
Home > Patient Care > Medicine > Ibrutinib > What Ibrutinib treats

Ibrutinib

Drug Class: Commonly Known As: Category:
Bruton Tyrosine Kinase Inhibitor Imbruvica® Cancer-related

Ibrutinib - What is it for

Ibrutinib is a targeted medication used to treat chronic lymphocytic leukemia, Waldenström’s macroglobulinemia and mantle cell lymphoma.

Ibrutinib - Additional Information

  • Updated on 2/28/2019 12:00:00 AM
  • Article contributed by Department of Pharmacy National Cancer Centre Singapore
The information provided is not intended as medical advice. Terms of use. Information provided by SingHealth

​​

Find Your Medicines

  • medication icon

    Learn about use of medicines, side effects and proper storage.

My Health Tools

Request/ Change appointment

Find a Specialist

SingHealth Updates for Healthcare Professionals

HealthXchange E-news Subscription

Health Buddy App

About Us
Patient Care
Research & Innovation
Education & Training
Careers
Giving
SingHealth
SingHealth Duke-NUS
11 Jalan Tan Tock Seng, Singapore 308433
Award1Award2Award3Award4
© 2024 SingHealth Group. All Rights Reserved.

Best viewed on IE 11, Firefox 27, Chrome 22, and Safari 7 and above.